Carmot Therapeutics, Inc.

Carmot Therapeutics, Inc.

Latest funding
$47,000,000
Venture capital (Series C) - 2020
Horizons Ventures The Column Group Amgen +1
Team Size
1–10
Employees
$47,000,000 Venture capital (Series C)
FinSMEs

Carmot Therapeutics Closes $47M Series C Financing